
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Lenka Stolařová, Petra Kleiblová, Markéta Janatová, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2675-2675
Open Access | Times Cited: 153
Lenka Stolařová, Petra Kleiblová, Markéta Janatová, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2675-2675
Open Access | Times Cited: 153
Showing 1-25 of 153 citing articles:
Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
Mattia Garutti, Lorenzo Foffano, Roberta Mazzeo, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1025-1025
Open Access | Times Cited: 43
Mattia Garutti, Lorenzo Foffano, Roberta Mazzeo, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1025-1025
Open Access | Times Cited: 43
A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization
Chunlu Li, Chengsi Deng, Siwei Wang, et al.
Redox Biology (2024) Vol. 70, pp. 103059-103059
Open Access | Times Cited: 30
Chunlu Li, Chengsi Deng, Siwei Wang, et al.
Redox Biology (2024) Vol. 70, pp. 103059-103059
Open Access | Times Cited: 30
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 29
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 29
Association of Germline Pathogenic Variants in MUTYH and Other DNA Damage Response Genes With Lung Cancer Risk Among Non-Hispanic Whites and African Americans
Matthew R. Trendowski, Christine M. Lusk, Angela S. Wenzlaff, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Matthew R. Trendowski, Christine M. Lusk, Angela S. Wenzlaff, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Blood (2021) Vol. 139, Iss. 8, pp. 1208-1221
Open Access | Times Cited: 73
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Blood (2021) Vol. 139, Iss. 8, pp. 1208-1221
Open Access | Times Cited: 73
Homologous Recombination Deficiencies and Hereditary Tumors
Hideki Yamamoto, Akira Hirasawa
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 348-348
Open Access | Times Cited: 61
Hideki Yamamoto, Akira Hirasawa
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 348-348
Open Access | Times Cited: 61
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
Shuangying Li, Liangliang Wang, Yuanyuan Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Shuangying Li, Liangliang Wang, Yuanyuan Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis
Xiaoxue Lu, Qiaolin Xu, Yanan Tong, et al.
Cell Reports (2022) Vol. 40, Iss. 3, pp. 111127-111127
Open Access | Times Cited: 40
Xiaoxue Lu, Qiaolin Xu, Yanan Tong, et al.
Cell Reports (2022) Vol. 40, Iss. 3, pp. 111127-111127
Open Access | Times Cited: 40
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test?
Francesca Rebuzzi, Paola Ulivi, Gianluca Tedaldi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2137-2137
Open Access | Times Cited: 36
Francesca Rebuzzi, Paola Ulivi, Gianluca Tedaldi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2137-2137
Open Access | Times Cited: 36
A large-scale genome-wide association study on female genital tract polyps highlights role of DNA repair, cell proliferation, and cell growth
Amruta D. S. Pathare, Jelisaveta Džigurski, Natàlia Pujol‐Gualdo, et al.
Human Reproduction (2025)
Closed Access | Times Cited: 1
Amruta D. S. Pathare, Jelisaveta Džigurski, Natàlia Pujol‐Gualdo, et al.
Human Reproduction (2025)
Closed Access | Times Cited: 1
Functional Analysis Identifies DamagingCHEK2Missense Variants Associated with Increased Cancer Risk
Rick A.C.M. Boonen, Wouter W. Wiegant, Nandi Celosse, et al.
Cancer Research (2021) Vol. 82, Iss. 4, pp. 615-631
Open Access | Times Cited: 44
Rick A.C.M. Boonen, Wouter W. Wiegant, Nandi Celosse, et al.
Cancer Research (2021) Vol. 82, Iss. 4, pp. 615-631
Open Access | Times Cited: 44
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
Caner Saygin, Gregory W. Roloff, Christopher N Hahn, et al.
Blood Advances (2022) Vol. 7, Iss. 4, pp. 549-554
Open Access | Times Cited: 33
Caner Saygin, Gregory W. Roloff, Christopher N Hahn, et al.
Blood Advances (2022) Vol. 7, Iss. 4, pp. 549-554
Open Access | Times Cited: 33
A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
Zhuo Chen, Xiao Liu, Zhengjie Zhu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 30
Zhuo Chen, Xiao Liu, Zhengjie Zhu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 30
CHEK2 variants: linking functional impact to cancer risk
Rick A.C.M. Boonen, Maaike P.G. Vreeswijk, Haico van Attikum
Trends in cancer (2022) Vol. 8, Iss. 9, pp. 759-770
Closed Access | Times Cited: 29
Rick A.C.M. Boonen, Maaike P.G. Vreeswijk, Haico van Attikum
Trends in cancer (2022) Vol. 8, Iss. 9, pp. 759-770
Closed Access | Times Cited: 29
ENIGMACHEK2gether Project: A Comprehensive Study Identifies Functionally ImpairedCHEK2Germline Missense Variants Associated with Increased Breast Cancer Risk
Lenka Stolařová, Petra Kleiblová, Petra Zemánková, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 3037-3050
Open Access | Times Cited: 18
Lenka Stolařová, Petra Kleiblová, Petra Zemánková, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 3037-3050
Open Access | Times Cited: 18
Rate of Pathogenic Germline Variants in Patients With Lung Cancer
Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 18
Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 18
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
Ryan J. Stubbins, Sophia C. Korotev, Lucy A. Godley
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 4, pp. 94-104
Closed Access | Times Cited: 24
Ryan J. Stubbins, Sophia C. Korotev, Lucy A. Godley
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 4, pp. 94-104
Closed Access | Times Cited: 24
DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
María Ovejero-Sánchez, Rogelio González‐Sarmiento, Ana B. Herrero
Cancers (2023) Vol. 15, Iss. 2, pp. 448-448
Open Access | Times Cited: 13
María Ovejero-Sánchez, Rogelio González‐Sarmiento, Ana B. Herrero
Cancers (2023) Vol. 15, Iss. 2, pp. 448-448
Open Access | Times Cited: 13
CHEK2 signaling is the key regulator of oocyte survival after chemotherapy
Chihiro Emori, Zachary Boucher, Ewelina Bolcun‐Filas
Science Advances (2023) Vol. 9, Iss. 42
Open Access | Times Cited: 13
Chihiro Emori, Zachary Boucher, Ewelina Bolcun‐Filas
Science Advances (2023) Vol. 9, Iss. 42
Open Access | Times Cited: 13
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 652-652
Open Access | Times Cited: 4
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 652-652
Open Access | Times Cited: 4
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
Michelle F. Jacobs, Elena M. Stoffel
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 221-232
Closed Access | Times Cited: 4
Michelle F. Jacobs, Elena M. Stoffel
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 221-232
Closed Access | Times Cited: 4
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history
Bojin Zhao, Jiaheng Li, Siddharth Sinha, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Bojin Zhao, Jiaheng Li, Siddharth Sinha, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Characterization of a pleomorphic rhabdomyosarcoma cell line
Sandra Stickler, Clemens Lang, Maximilian Rieche, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sandra Stickler, Clemens Lang, Maximilian Rieche, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Germinal pathogenic CHEK2, novel APC and somatic JAK2V617F variants in a young patient with colorectal cancer, atypical leukemia, cerebral tumour and aggressive course
L. Rojas, J. Rodriguez, Sebastián Navarrete, et al.
ecancermedicalscience (2025) Vol. 19
Open Access
L. Rojas, J. Rodriguez, Sebastián Navarrete, et al.
ecancermedicalscience (2025) Vol. 19
Open Access
Exploring the genetic correlation and causal relationships between breast cancer and meningioma using bidirectional Mendelian randomization
Lu Ding, Bo Chen, Zhou Zhou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lu Ding, Bo Chen, Zhou Zhou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access